Morphosis Capital

Bucharest, Romania ·
Tier 2 Industrial

Bio

Morphosis Capital Morphosis Capital was founded in 2018 by four Romanian entrepreneurs as a CEE SME- focused PE firm. Fund II closed at €130M (oversubscribed), backed by EIF, EBRD, and IFC. Check sizes run €10-15M targeting companies with €1-5M EBITDA. The portfolio of 8 companies has €197M in combined 2023 turnover and 1,500 jobs. The deep tech highlight is EnduroSat. a leading European nanosatellite provider. Other portfolio companies include DocProcess (exited), Medima Health, EMI, Cronos Me

Industries

Advanced ManufacturingMedTechSpace Tech

Stages

Series ASeries B+

Geography

Europe

Notable investments

  • EnduroSat